Amon R. Wafelman - Concepedia

Concepedia

Author

Amon R. Wafelman

Leiden University Medical Center

Also Known As

A. R. WAFELMAN, A. R. Wafelman, A. Wafelman, A.R. Wafelman, Amon R Wafelman, Amon R. Wafelman, Amon Wafelman

25

Publications

2.5K

Citations

14

H-Index

28

Concepts

All Affiliations

Leiden University Medical Center Slotervaartziekenhuis The Netherlands Cancer Institute Institute of Haematology and Blood Transfusion Medisch Centrum Leeuwarden

AR

About

Amon R. Wafelman is an author at Leiden University Medical Center specializing in medicine, pharmacology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	279
2	Health Sciences	1	1	55
3	Blood Transplantation	1	1	55
4	Cell Biology	1	1	55
5	Cellular Therapies	1	1	55

Amon R. Wafelman

×

16

Publications

2.5K

Citations

13

H-Index

	Year	Citations
Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia Gemma G. Kenter, Marij J.P. Welters, A. Rob P.M. Valentijn, New England Journal of Medicine	2009	1.1K
Induction of Tumor-Specific CD4+ and CD8+ T-Cell Immunity in Cervical Cancer Patients by a Human Papillomavirus Type 16 E6 and E7 Long Peptides Vaccine Marij J.P. Welters, Gemma G. Kenter, Sytse J. Piersma, Clinical Cancer Research	2008	365
Phase I Immunotherapeutic Trial with Long Peptides Spanning the E6 and E7 Sequences of High-Risk Human Papillomavirus 16 in End-Stage Cervical Cancer Patients Shows Low Toxicity and Robust Immunogenicity Gemma G. Kenter, Marij J.P. Welters, A. Rob P.M. Valentijn, Clinical Cancer Research	2008	308
Complete Remission of Accelerated Phase Chronic Myeloid Leukemia by Treatment With Leukemia-Reactive Cytotoxic T Lymphocytes J.H. Frederik Falkenburg, Amon R. Wafelman, Peter Joosten, Blood	1999	269
Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for therapeutic application Marja J. Nell, G. Sandra Tjabringa, Amon R. Wafelman, Peptides Novel Ll-37MedicinePeptide LibraryImmunologyLta Neutralizing	2005	172
Generation and administration of HA-1-specific T-cell lines for the treatment of patients with relapsed leukemia after allogeneic stem cell transplantation: a pilot study Pauline Meij, Inge Jedema, Menno A. W. G. van der Hoorn, Haematologica Cell TherapyImmunologyImmunotherapyPilot StudyHematological Malignancy	2012	55
Phase I/II feasibility study evaluating the generation of leukemia-reactive cytotoxic T lymphocyte lines for treatment of patients with relapsed leukemia after allogeneic stem cell transplantation Erik W.A. Marijt, Amon R. Wafelman, Menno van der Hoorn, Haematologica	2007	45
Skin reactions to human papillomavirus (HPV) 16 specific antigens intradermally injected in healthy subjects and patients with cervical neoplasia Muriel van den Hende, Mariëtte I.E. van Poelgeest, Jeanette M. van der Hulst, International Journal of Cancer	2008	36
Ototopical drops containing a novel antibacterial synthetic peptide: Safety and efficacy in adults with chronic suppurative otitis media Nanno F. A. W. Peek, Marja J. Nell, Ronald Brand, PLoS ONE	2020	28
Renal excretion of iodine-131 labelledmeta-iodobenzylguanidine and metabolites after therapeutic doses in patients suffering from different neural crest-derived tumours Amon R. Wafelman, Cornelis A. Hoefnagel, H. Maessen, European Journal of Nuclear Medicine and Molecular Imaging Neuro-oncologyOncologyTumor InnervationMalignant DiseaseMedicine	1997	26

Page 1